APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

MET TKIs

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global MET TKIs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 174012390327 December 2025192 pages

Choose your research edition.

Industry ResearchMET TKIs Industry Research Report 2026132 pages · $2,950 USDIndustry Growth & TrendsGlobal MET TKIs Industry Growth and Trends Forecast to 2032117 pages · $3,450 USDMarket StructureGlobal MET TKIs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal MET TKIs Market Outlook and Growth Opportunities 2026209 pages · $4,250 USDMarket Analysis & ForecastGlobal MET TKIs Market Analysis and Forecast 2026-2032208 pages · $4,950 USD

Market perspective

The global MET TKIs market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for MET TKIs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for MET TKIs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for MET TKIs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for MET TKIs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of MET TKIs include Wanbang Biopharmaceuticals, CSPC Pharmaceutical, Asymchem, Shanghai Hutchison Pharmaceuticals, WuXi STA, Haihe Biopharma, Avistone Pharmaceuticals Biotechnology, Zydus and Teva, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global MET TKIs market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of MET TKIs and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents MET TKIs sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the MET TKIs market size, projected growth trends, production technologies, key applications, and end-use industries.

MET TKIs Segment by Company

Wanbang Biopharmaceuticals

CSPC Pharmaceutical

Asymchem

Shanghai Hutchison Pharmaceuticals

WuXi STA

Haihe Biopharma

Avistone Pharmaceuticals Biotechnology

Zydus

Teva

Pfizer

Novartis

Merck

Genvio Pharma

Exelixis

Everest Pharmaceuticals

Drug International

Cipla

Beacom

BDR Pharma

MET TKIs Segment by Type

Multi-target Inhibitors

Single-target Inhibitors

MET TKIs Segment by Application

Non-small Cell Lung Cancer

Medullary Thyroid Cancer

Other

MET TKIs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global MET TKIs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of MET TKIs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of MET TKIs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the MET TKIs market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of MET TKIs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of MET TKIs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of MET TKIs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. MET TKIs Industry Trends Table 2. MET TKIs Industry Drivers Table 3. MET TKIs Industry Opportunities and Challenges Table 4. MET TKIs Industry Restraints Table 5. Global MET TKIs Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global MET TKIs Revenue Market Share by Manufacturers (2021-2026) Table 7. Global MET TKIs Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global MET TKIs Sales Market Share by Manufacturers Table 9. Global MET TKIs Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global MET TKIs Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global MET TKIs Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global MET TKIs Manufacturers, Product Type & Application Table 13. Global MET TKIs Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global MET TKIs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Multi-target Inhibitors Table 17. Major Manufacturers of Single-target Inhibitors Table 18. Global MET TKIs Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global MET TKIs Sales by Type (2021-2026) & (K Units) Table 20. Global MET TKIs Sales by Type (2027-2032) & (K Units) Table 21. Global MET TKIs Sales Market Share by Type (2021-2026) Table 22. Global MET TKIs Sales Market Share by Type (2027-2032) Table 23. Global MET TKIs Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global MET TKIs Revenue by Type (2021-2026) & (K Units) Table 25. Global MET TKIs Revenue by Type (2027-2032) & (K Units) Table 26. Global MET TKIs Revenue Market Share by Type (2021-2026) Table 27. Global MET TKIs Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Non-small Cell Lung Cancer Table 29. Major Manufacturers of Medullary Thyroid Cancer Table 30. Major Manufacturers of Other Table 31. Global MET TKIs Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 32. Global MET TKIs Sales by Application (2021-2026) & (K Units) Table 33. Global MET TKIs Sales by Application (2027-2032) & (K Units) Table 34. Global MET TKIs Sales Market Share by Application (2021-2026) Table 35. Global MET TKIs Sales Market Share by Application (2027-2032) Table 36. Global MET TKIs Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 37. Global MET TKIs Revenue by Application (2021-2026) & (K Units) Table 38. Global MET TKIs Revenue by Application (2027-2032) & (K Units) Table 39. Global MET TKIs Revenue Market Share by Application (2021-2026) Table 40. Global MET TKIs Revenue Market Share by Application (2027-2032) Table 41. Global MET TKIs Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 42. Global MET TKIs Sales by Region (2021-2026) & (K Units) Table 43. Global MET TKIs Sales Market Share by Region (2021-2026) Table 44. Global MET TKIs Sales Forecasted by Region (2027-2032) & (K Units) Table 45. Global MET TKIs Sales Forecasted Market Share by Region (2027-2032) Table 46. North America MET TKIs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 47. North America MET TKIs Sales by Country (2021-2026) & (K Units) Table 48. North America MET TKIs Sales by Country (2027-2032) & (K Units) Table 49. Europe MET TKIs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. Europe MET TKIs Sales by Country (2021-2026) & (K Units) Table 51. Europe MET TKIs Sales by Country (2027-2032) & (K Units) Table 52. Asia Pacific MET TKIs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Asia Pacific MET TKIs Sales by Country (2021-2026) & (K Units) Table 54. Asia Pacific MET TKIs Sales by Country (2027-2032) & (K Units) Table 55. South America, Middle East and Africa MET TKIs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. South America, Middle East and Africa MET TKIs Sales by Country (2021-2026) & (K Units) Table 57. South America, Middle East and Africa MET TKIs Sales by Country (2027-2032) & (K Units) Table 58. Global MET TKIs Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global MET TKIs Revenue by Region (2021-2026) & (US$ Million) Table 60. Global MET TKIs Revenue by Region (2027-2032) & (US$ Million) Table 61. Global MET TKIs Revenue Market Share by Region (2021-2026) Table 62. Global MET TKIs Revenue Market Share by Region (2027-2032) Table 63. Wanbang Biopharmaceuticals Company Information Table 64. Wanbang Biopharmaceuticals Business Overview Table 65. Wanbang Biopharmaceuticals MET TKIs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Wanbang Biopharmaceuticals MET TKIs Product Portfolio Table 67. Wanbang Biopharmaceuticals Recent Development Table 68. CSPC Pharmaceutical Company Information Table 69. CSPC Pharmaceutical Business Overview Table 70. CSPC Pharmaceutical MET TKIs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. CSPC Pharmaceutical MET TKIs Product Portfolio Table 72. CSPC Pharmaceutical Recent Development Table 73. Asymchem Company Information Table 74. Asymchem Business Overview Table 75. Asymchem MET TKIs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Asymchem MET TKIs Product Portfolio Table 77. Asymchem Recent Development Table 78. Shanghai Hutchison Pharmaceuticals Company Information Table 79. Shanghai Hutchison Pharmaceuticals Business Overview Table 80. Shanghai Hutchison Pharmaceuticals MET TKIs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Shanghai Hutchison Pharmaceuticals MET TKIs Product Portfolio Table 82. Shanghai Hutchison Pharmaceuticals Recent Development Table 83. WuXi STA Company Information Table 84. WuXi STA Business Overview Table 85. WuXi STA MET TKIs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. WuXi STA MET TKIs Product Portfolio Table 87. WuXi STA Recent Development Table 88. Haihe Biopharma Company Information Table 89. Haihe Biopharma Business Overview Table 90. Haihe Biopharma MET TKIs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Haihe Biopharma MET TKIs Product Portfolio Table 92. Haihe Biopharma Recent Development Table 93. Avistone Pharmaceuticals Biotechnology Company Information Table 94. Avistone Pharmaceuticals Biotechnology Business Overview Table 95. Avistone Pharmaceuticals Biotechnology MET TKIs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Avistone Pharmaceuticals Biotechnology MET TKIs Product Portfolio Table 97. Avistone Pharmaceuticals Biotechnology Recent Development Table 98. Zydus Company Information Table 99. Zydus Business Overview Table 100. Zydus MET TKIs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Zydus MET TKIs Product Portfolio Table 102. Zydus Recent Development Table 103. Teva Company Information Table 104. Teva Business Overview Table 105. Teva MET TKIs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Teva MET TKIs Product Portfolio Table 107. Teva Recent Development Table 108. Pfizer Company Information Table 109. Pfizer Business Overview Table 110. Pfizer MET TKIs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Pfizer MET TKIs Product Portfolio Table 112. Pfizer Recent Development Table 113. Novartis Company Information Table 114. Novartis Business Overview Table 115. Novartis MET TKIs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. Novartis MET TKIs Product Portfolio Table 117. Novartis Recent Development Table 118. Merck Company Information Table 119. Merck Business Overview Table 120. Merck MET TKIs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 121. Merck MET TKIs Product Portfolio Table 122. Merck Recent Development Table 123. Genvio Pharma Company Information Table 124. Genvio Pharma Business Overview Table 125. Genvio Pharma MET TKIs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 126. Genvio Pharma MET TKIs Product Portfolio Table 127. Genvio Pharma Recent Development Table 128. Exelixis Company Information Table 129. Exelixis Business Overview Table 130. Exelixis MET TKIs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 131. Exelixis MET TKIs Product Portfolio Table 132. Exelixis Recent Development Table 133. Everest Pharmaceuticals Company Information Table 134. Everest Pharmaceuticals Business Overview Table 135. Everest Pharmaceuticals MET TKIs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 136. Everest Pharmaceuticals MET TKIs Product Portfolio Table 137. Everest Pharmaceuticals Recent Development Table 138. Drug International Company Information Table 139. Drug International Business Overview Table 140. Drug International MET TKIs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 141. Drug International MET TKIs Product Portfolio Table 142. Drug International Recent Development Table 143. Cipla Company Information Table 144. Cipla Business Overview Table 145. Cipla MET TKIs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 146. Cipla MET TKIs Product Portfolio Table 147. Cipla Recent Development Table 148. Beacom Company Information Table 149. Beacom Business Overview Table 150. Beacom MET TKIs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 151. Beacom MET TKIs Product Portfolio Table 152. Beacom Recent Development Table 153. BDR Pharma Company Information Table 154. BDR Pharma Business Overview Table 155. BDR Pharma MET TKIs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 156. BDR Pharma MET TKIs Product Portfolio Table 157. BDR Pharma Recent Development Table 158. Key Raw Materials Table 159. Raw Materials Key Suppliers Table 160. MET TKIs Distributors List Table 161. MET TKIs Customers List Table 162. Research Programs/Design for This Report Table 163. Authors List of This Report Table 164. Secondary Sources Table 165. Primary Sources List of Figures Figure 1. MET TKIs Product Image Figure 2. Global MET TKIs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global MET TKIs Market Size (2021-2032) & (US$ Million) Figure 4. Global MET TKIs Sales (2021-2032) & (K Units) Figure 5. Global MET TKIs Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 MET TKIs Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Multi-target Inhibitors Image Figure 9. Single-target Inhibitors Image Figure 10. Global MET TKIs Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global MET TKIs Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global MET TKIs Sales Market Share by Type (2021-2032) Figure 13. Global MET TKIs Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global MET TKIs Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global MET TKIs Revenue Market Share by Type (2021-2032) Figure 16. Non-small Cell Lung Cancer Image Figure 17. Medullary Thyroid Cancer Image Figure 18. Other Image Figure 19. Global MET TKIs Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global MET TKIs Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global MET TKIs Sales Market Share by Application (2021-2032) Figure 22. Global MET TKIs Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global MET TKIs Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global MET TKIs Revenue Market Share by Application (2021-2032) Figure 25. North America MET TKIs Sales and Growth Rate (2021-2032) & (K Units) Figure 26. North America MET TKIs Sales Market Share by Country (2021-2032) Figure 27. U.S. MET TKIs Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Canada MET TKIs Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Mexico MET TKIs Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe MET TKIs Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe MET TKIs Sales Market Share by Country (2021-2032) Figure 32. Germany MET TKIs Sales and Growth Rate (2021-2032) & (K Units) Figure 33. France MET TKIs Sales and Growth Rate (2021-2032) & (K Units) Figure 34. U.K. MET TKIs Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Italy MET TKIs Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Netherlands MET TKIs Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific MET TKIs Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific MET TKIs Sales Market Share by Country (2021-2032) Figure 39. China MET TKIs Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Japan MET TKIs Sales and Growth Rate (2021-2032) & (K Units) Figure 41. South Korea MET TKIs Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Southeast Asia MET TKIs Sales and Growth Rate (2021-2032) & (K Units) Figure 43. India MET TKIs Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Australia MET TKIs Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa MET TKIs Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa MET TKIs Sales Market Share by Country (2021-2032) Figure 47. Brazil MET TKIs Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South Africa MET TKIs Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Saudi Arabia MET TKIs Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Turkey MET TKIs Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Argentina MET TKIs Sales and Growth Rate (2021-2032) & (K Units) Figure 52. UAE MET TKIs Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Egypt MET TKIs Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Chile MET TKIs Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Global MET TKIs Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global MET TKIs Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America MET TKIs Revenue (2021-2032) & (US$ Million) Figure 58. North America MET TKIs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe MET TKIs Revenue (2021-2032) & (US$ Million) Figure 60. Europe MET TKIs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific MET TKIs Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific MET TKIs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa MET TKIs Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa MET TKIs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. MET TKIs Value Chain Figure 66. Manufacturing Cost Structure Figure 67. MET TKIs Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Multi-target Inhibitors
  • Single-target Inhibitors
Applications
  • Non-small Cell Lung Cancer
  • Medullary Thyroid Cancer
  • Other
Companies covered
  • Wanbang Biopharmaceuticals
  • CSPC Pharmaceutical
  • Asymchem
  • Shanghai Hutchison Pharmaceuticals
  • WuXi STA
  • Haihe Biopharma
  • Avistone Pharmaceuticals Biotechnology
  • Zydus
  • Teva
  • Pfizer
  • Novartis
  • Merck
  • Genvio Pharma
  • Exelixis
  • Everest Pharmaceuticals
  • Drug International
  • Cipla
  • Beacom
  • BDR Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global MET TKIs Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global MET TKIs Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global MET TKIs Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global MET TKIs Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global MET TKIs Market Dynamics
  1. 2.1 MET TKIs Industry Trends
  2. 2.2 MET TKIs Industry Drivers
  3. 2.3 MET TKIs Industry Opportunities and Challenges
  4. 2.4 MET TKIs Industry Restraints
3 MET TKIs Market by Manufacturers
  1. 3.1 Global MET TKIs Revenue by Manufacturers (2021-2026)
  2. 3.2 Global MET TKIs Sales by Manufacturers (2021-2026)
  3. 3.3 Global MET TKIs Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global MET TKIs Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global MET TKIs Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global MET TKIs Manufacturers, Product Type & Application
  7. 3.7 Global MET TKIs Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global MET TKIs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 MET TKIs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 MET TKIs Tier 1, Tier 2, and Tier 3
4 MET TKIs Market by Type
  1. 4.1 MET TKIs Type Introduction
  2. 4.1.1 Multi-target Inhibitors
  3. 4.1.2 Single-target Inhibitors
  4. 4.2 Global MET TKIs Sales by Type
  5. 4.2.1 Global MET TKIs Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global MET TKIs Sales by Type (2021-2032)
  7. 4.2.3 Global MET TKIs Sales Market Share by Type (2021-2032)
  8. 4.3 Global MET TKIs Revenue by Type
  9. 4.3.1 Global MET TKIs Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global MET TKIs Revenue by Type (2021-2032)
  11. 4.3.3 Global MET TKIs Revenue Market Share by Type (2021-2032)
5 MET TKIs Market by Application
  1. 5.1 MET TKIs Application Introduction
  2. 5.1.1 Non-small Cell Lung Cancer
  3. 5.1.2 Medullary Thyroid Cancer
  4. 5.1.3 Other
  5. 5.2 Global MET TKIs Sales by Application
  6. 5.2.1 Global MET TKIs Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global MET TKIs Sales by Application (2021-2032)
  8. 5.2.3 Global MET TKIs Sales Market Share by Application (2021-2032)
  9. 5.3 Global MET TKIs Revenue by Application
  10. 5.3.1 Global MET TKIs Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global MET TKIs Revenue by Application (2021-2032)
  12. 5.3.3 Global MET TKIs Revenue Market Share by Application (2021-2032)
6 Global MET TKIs Sales by Region
  1. 6.1 Global MET TKIs Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global MET TKIs Sales by Region (2021-2032)
  3. 6.2.1 Global MET TKIs Sales by Region (2021-2026)
  4. 6.2.2 Global MET TKIs Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America MET TKIs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America MET TKIs Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe MET TKIs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe MET TKIs Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific MET TKIs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific MET TKIs Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa MET TKIs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa MET TKIs Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global MET TKIs Revenue by Region
  1. 7.1 Global MET TKIs Revenue by Region
  2. 7.1.1 Global MET TKIs Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global MET TKIs Revenue by Region (2021-2026)
  4. 7.1.3 Global MET TKIs Revenue by Region (2027-2032)
  5. 7.1.4 Global MET TKIs Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America MET TKIs Revenue (2021-2032)
  8. 7.2.2 North America MET TKIs Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe MET TKIs Revenue (2021-2032)
  11. 7.3.2 Europe MET TKIs Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific MET TKIs Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific MET TKIs Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa MET TKIs Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa MET TKIs Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Wanbang Biopharmaceuticals
  2. 8.1.1 Wanbang Biopharmaceuticals Company Information
  3. 8.1.2 Wanbang Biopharmaceuticals Business Overview
  4. 8.1.3 Wanbang Biopharmaceuticals MET TKIs Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Wanbang Biopharmaceuticals MET TKIs Product Portfolio
  6. 8.1.5 Wanbang Biopharmaceuticals Recent Developments
  7. 8.2 CSPC Pharmaceutical
  8. 8.2.1 CSPC Pharmaceutical Company Information
  9. 8.2.2 CSPC Pharmaceutical Business Overview
  10. 8.2.3 CSPC Pharmaceutical MET TKIs Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 CSPC Pharmaceutical MET TKIs Product Portfolio
  12. 8.2.5 CSPC Pharmaceutical Recent Developments
  13. 8.3 Asymchem
  14. 8.3.1 Asymchem Company Information
  15. 8.3.2 Asymchem Business Overview
  16. 8.3.3 Asymchem MET TKIs Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Asymchem MET TKIs Product Portfolio
  18. 8.3.5 Asymchem Recent Developments
  19. 8.4 Shanghai Hutchison Pharmaceuticals
  20. 8.4.1 Shanghai Hutchison Pharmaceuticals Company Information
  21. 8.4.2 Shanghai Hutchison Pharmaceuticals Business Overview
  22. 8.4.3 Shanghai Hutchison Pharmaceuticals MET TKIs Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Shanghai Hutchison Pharmaceuticals MET TKIs Product Portfolio
  24. 8.4.5 Shanghai Hutchison Pharmaceuticals Recent Developments
  25. 8.5 WuXi STA
  26. 8.5.1 WuXi STA Company Information
  27. 8.5.2 WuXi STA Business Overview
  28. 8.5.3 WuXi STA MET TKIs Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 WuXi STA MET TKIs Product Portfolio
  30. 8.5.5 WuXi STA Recent Developments
  31. 8.6 Haihe Biopharma
  32. 8.6.1 Haihe Biopharma Company Information
  33. 8.6.2 Haihe Biopharma Business Overview
  34. 8.6.3 Haihe Biopharma MET TKIs Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Haihe Biopharma MET TKIs Product Portfolio
  36. 8.6.5 Haihe Biopharma Recent Developments
  37. 8.7 Avistone Pharmaceuticals Biotechnology
  38. 8.7.1 Avistone Pharmaceuticals Biotechnology Company Information
  39. 8.7.2 Avistone Pharmaceuticals Biotechnology Business Overview
  40. 8.7.3 Avistone Pharmaceuticals Biotechnology MET TKIs Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Avistone Pharmaceuticals Biotechnology MET TKIs Product Portfolio
  42. 8.7.5 Avistone Pharmaceuticals Biotechnology Recent Developments
  43. 8.8 Zydus
  44. 8.8.1 Zydus Company Information
  45. 8.8.2 Zydus Business Overview
  46. 8.8.3 Zydus MET TKIs Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Zydus MET TKIs Product Portfolio
  48. 8.8.5 Zydus Recent Developments
  49. 8.9 Teva
  50. 8.9.1 Teva Company Information
  51. 8.9.2 Teva Business Overview
  52. 8.9.3 Teva MET TKIs Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Teva MET TKIs Product Portfolio
  54. 8.9.5 Teva Recent Developments
  55. 8.10 Pfizer
  56. 8.10.1 Pfizer Company Information
  57. 8.10.2 Pfizer Business Overview
  58. 8.10.3 Pfizer MET TKIs Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Pfizer MET TKIs Product Portfolio
  60. 8.10.5 Pfizer Recent Developments
  61. 8.11 Novartis
  62. 8.11.1 Novartis Company Information
  63. 8.11.2 Novartis Business Overview
  64. 8.11.3 Novartis MET TKIs Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Novartis MET TKIs Product Portfolio
  66. 8.11.5 Novartis Recent Developments
  67. 8.12 Merck
  68. 8.12.1 Merck Company Information
  69. 8.12.2 Merck Business Overview
  70. 8.12.3 Merck MET TKIs Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Merck MET TKIs Product Portfolio
  72. 8.12.5 Merck Recent Developments
  73. 8.13 Genvio Pharma
  74. 8.13.1 Genvio Pharma Company Information
  75. 8.13.2 Genvio Pharma Business Overview
  76. 8.13.3 Genvio Pharma MET TKIs Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Genvio Pharma MET TKIs Product Portfolio
  78. 8.13.5 Genvio Pharma Recent Developments
  79. 8.14 Exelixis
  80. 8.14.1 Exelixis Company Information
  81. 8.14.2 Exelixis Business Overview
  82. 8.14.3 Exelixis MET TKIs Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Exelixis MET TKIs Product Portfolio
  84. 8.14.5 Exelixis Recent Developments
  85. 8.15 Everest Pharmaceuticals
  86. 8.15.1 Everest Pharmaceuticals Company Information
  87. 8.15.2 Everest Pharmaceuticals Business Overview
  88. 8.15.3 Everest Pharmaceuticals MET TKIs Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Everest Pharmaceuticals MET TKIs Product Portfolio
  90. 8.15.5 Everest Pharmaceuticals Recent Developments
  91. 8.16 Drug International
  92. 8.16.1 Drug International Company Information
  93. 8.16.2 Drug International Business Overview
  94. 8.16.3 Drug International MET TKIs Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Drug International MET TKIs Product Portfolio
  96. 8.16.5 Drug International Recent Developments
  97. 8.17 Cipla
  98. 8.17.1 Cipla Company Information
  99. 8.17.2 Cipla Business Overview
  100. 8.17.3 Cipla MET TKIs Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Cipla MET TKIs Product Portfolio
  102. 8.17.5 Cipla Recent Developments
  103. 8.18 Beacom
  104. 8.18.1 Beacom Company Information
  105. 8.18.2 Beacom Business Overview
  106. 8.18.3 Beacom MET TKIs Sales, Price, Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Beacom MET TKIs Product Portfolio
  108. 8.18.5 Beacom Recent Developments
  109. 8.19 BDR Pharma
  110. 8.19.1 BDR Pharma Company Information
  111. 8.19.2 BDR Pharma Business Overview
  112. 8.19.3 BDR Pharma MET TKIs Sales, Price, Revenue and Gross Margin (2021-2026)
  113. 8.19.4 BDR Pharma MET TKIs Product Portfolio
  114. 8.19.5 BDR Pharma Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 MET TKIs Value Chain Analysis
  2. 9.1.1 MET TKIs Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 MET TKIs Production Mode & Process
  6. 9.2 MET TKIs Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 MET TKIs Distributors
  9. 9.2.3 MET TKIs Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst